Cell And Gene Therapy Upstream Optimization
-
CTS DynaCellect Fluidics Demonstration
6/9/2025
Streamline and customize your cell processing workflow with automated, precise control over fluid movement and transfer parameters.
-
Thermo Fisher Scientific Customer Experience Center Overview
5/19/2025
Explore cutting-edge single-use technologies with hands-on training at the Customer Experience Center, which is an immersive hub for innovation, learning, and bioprocessing expertise.
-
Technology Needs For Automated Manufacturing
8/18/2023
Investigate the importance of technology as it relates to automation and standardization within cell therapy manufacturing. The panelists in this discussion cover solutions and services needed for process automation in CGT.
-
Pipeline Progress
8/18/2023
Experts working on robust pipelines that focus on various therapeutic areas explain how process automation looks different per therapeutic focus area.
-
Optimize Cell Isolation And Activation For Flexibility And Scalability
11/13/2023
Learn about a first-of-its-kind platform technology that enables isolation and activation of T cells in one step using an active release mechanism for clinical trial or commercial manufacturing.
-
CTS OpTmizer One SFM: Thoughtfully Designed Nutrition For T Cells
5/22/2025
Learn about a novel, next-generation medium with an animal-component-free formulation developed to support the need for a T-cell medium that allows consistent, reproducible, and automated T-cell manufacturing.
-
CTS DynaCellect Magnetic Separation System Cell Isolation
5/22/2025
Ready to achieve high-purity results in your cell therapy manufacturing? This step-by-step guide demonstrates the complete setup and installation for your automated magnetic cell isolation system and kit.
-
CTS DynaCellect Magnetic Separation System Uninstalling Bead Removal Kit
5/22/2025
Safely remove the bead removal kit from the CTS DynaCellect Magnetic Separation System. This video shows you how to remove the cassette and fluid lines.
-
A Collaboration With Fresenius Kabi BioPharm
5/19/2025
Explore how biosimilar development is advancing through collaboration, innovative cell culture strategies, and the use of advanced media to meet biomanufacturing goals.
-
Supporting Efficacy And Scaling With A Next-Generation T Cell AOF Formulation Medium
6/16/2025
Explore a novel, next-generation medium designed with an animal component-free formulation to boost therapeutic potential and enable reproducible T cells.